In the realm of compounding pharmacies, compliance with safety regulations and guidelines is essential for protecting both healthcare workers and patients. USP 797 and USP 800 are two critical guidelines established by the United States Pharmacopeia (USP). While both focus on maintaining safety and quality standards, they address different aspects of pharmaceutical practice. USP 797 is centered on sterile compounding, whereas USP 800 deals with the safe handling of hazardous drugs.
Understanding the differences between USP 797 and USP 800, and how they intersect, is crucial for pharmacy practices to ensure both safety and compliance. This blog will discuss the key differences between USP 800 and USP 797, their roles in pharmacy safety, and how these standards affect compounding pharmacy practices.
What Is USP 797?
USP 797 provides the guidelines for sterile compounding, specifically focusing on ensuring that compounded medications, such as intravenous (IV) solutions and injectable drugs, are free from contamination. Sterile compounding involves the preparation of medications in environments where sterility is critical to patient safety. USP 797 outlines the standards for controlling the potential for contamination and ensuring that medications meet quality standards before they are administered to patients.
The guidelines for USP 797 emphasize the following:
- Aseptic Techniques: Pharmacy staff involved in sterile compounding must be trained in aseptic techniques to prevent contamination. Aseptic technique refers to methods used to maintain sterility during the preparation, handling, and storage of compounded medications.
- Environmental Control: Compounding must take place in controlled environments. These environments include cleanrooms and laminar flow hoods where airflow and particle filtration systems are used to prevent contamination.
- Monitoring and Documentation: Compounding pharmacies must routinely monitor and document environmental conditions, as well as the sterility of the final compounded product. This includes frequent checks of cleanroom conditions, equipment calibration, and regular audits.
- Personnel Training: Compounding pharmacy employees must undergo specific training to handle sterile compounding, including education on the proper use of equipment, sanitation techniques, and quality control procedures.
In summary, USP 797 focuses on preventing microbial contamination in sterile medications, ensuring they are safe for patient use and reducing the risk of infections or adverse reactions.
What Is USP 800?
USP 800 focuses on the safe handling of hazardous drugs in all pharmaceutical settings, including compounding pharmacies. Hazardous drugs are defined as those that pose a risk to healthcare workers due to their toxicity. These drugs can cause various health problems, such as cancer, organ toxicity, and reproductive issues. Chemotherapy drugs, antiviral medications, and hormones are common examples of hazardous drugs.
The purpose of USP 800 is to minimize the exposure of healthcare workers to hazardous drugs while ensuring the safety and efficacy of the drugs for patients. The guidelines cover the following:
- Containment of Hazardous Drugs: The use of containment strategies such as biological safety cabinets (BSCs), compounding aseptic containment isolators (CACIs), and ventilated cabinets is necessary to protect pharmacy personnel from exposure to hazardous drugs.
- Personal Protective Equipment (PPE): USP 800 requires pharmacy staff to wear appropriate PPE, such as gloves, gowns, respirators, and face shields, when handling hazardous drugs. The use of double gloves and chemical-resistant gowns is standard to prevent drug exposure.
- Cleaning and Decontamination: Work surfaces and equipment that come into contact with hazardous drugs must be regularly cleaned and decontaminated using approved disinfectants. This helps to prevent the spread of contamination in the pharmacy environment.
- Waste Management: Proper procedures for the disposal of hazardous drugs and contaminated materials must be followed to minimize exposure to harmful substances. This includes the use of designated hazardous waste containers and ensuring proper disposal protocols.
In essence, USP 800 aims to protect pharmacy personnel, patients, and the environment from the harmful effects of hazardous drugs while ensuring that these drugs are prepared and administered in a safe and effective manner.
Key Differences Between USP 800 and USP 797
While both USP 797 and USP 800 deal with safety and regulatory compliance in pharmacy practice, their focus areas differ significantly. Below are the key distinctions between the two standards:
| Aspect | USP 797 | USP 800 |
| Focus Area | Sterile compounding and contamination control. | Handling of hazardous drugs and worker protection. |
| Primary Goal | Ensuring sterility in compounded medications. | Minimizing exposure to hazardous drugs. |
| Environmental Conditions | Requires controlled environments (cleanrooms, laminar flow hoods). | Requires containment systems (BSCs, CACIs). |
| Personnel Safety | Emphasis on aseptic techniques and sanitation. | Requires PPE (gloves, gowns, respirators) for handling hazardous drugs. |
| Waste Disposal | Guidelines for disposing of contaminated equipment. | Specific protocols for hazardous drug waste disposal. |
| Regulatory Bodies | Governed by the United States Pharmacopeia (USP). | Governed by USP and OSHA regulations. |
These key differences show that USP 797 is primarily concerned with maintaining sterility in compounded medications, while USP 800 focuses on reducing the risks associated with handling hazardous drugs. However, both standards share the goal of ensuring safety for both healthcare workers and patients.
The Role of USP 797 in Sterile Compounding
USP 797 plays a critical role in ensuring that compounded sterile medications are free from contamination. Compounded sterile preparations (CSPs) include injectable medications, IV fluids, and other drugs that are administered through sterile routes. The preparation of CSPs requires a high level of precision and attention to detail to prevent any potential contamination that could lead to infections, adverse reactions, or compromised drug efficacy.
Pharmacists and pharmacy technicians working in sterile compounding environments must follow USP 797 guidelines for:
- Maintaining a Clean Environment: Compounding must be performed in a cleanroom environment with proper airflow and filtration systems, such as laminar flow hoods, which are designed to minimize the risk of contamination.
- Aseptic Technique: Ensuring the compounding process is performed under sterile conditions is essential for patient safety. This includes hand hygiene, the use of sterile equipment, and preventing cross-contamination during preparation.
- Regular Audits and Monitoring: Continuous monitoring of the compounding environment, including routine environmental sampling, is required to ensure that the standards of sterility are maintained.
Ultimately, USP 797 is fundamental in safeguarding patients by ensuring that compounded sterile medications are free from microbial contamination and prepared under the highest standards of cleanliness. As highlighted in USP 797 guidelines, maintaining sterility in compounded medications, such as IV drugs and injections, is essential to prevent contamination and ensure patient safety.
The Role of USP 800 in Handling Hazardous Drugs
USP 800 plays an equally vital role in ensuring the safety of pharmacy staff who handle hazardous drugs. Exposure to hazardous drugs can result in serious health issues for healthcare workers, including cancer, reproductive toxicity, and organ damage. To mitigate these risks, USP 800 outlines strict guidelines on the proper handling, containment, and disposal of hazardous drugs.
Key practices within USP 800 include:
- Containment and Isolation: Using biological safety cabinets or compounding aseptic containment isolators (CACIs) is required to prevent hazardous drug particles from contaminating the air and workspace. These containment systems ensure that dangerous substances do not affect staff or contaminate the environment.
- Personal Protective Equipment (PPE): Pharmacy workers must wear appropriate PPE, including gloves, gowns, and respirators when working with hazardous drugs. The use of double gloves and chemical-resistant gowns ensures a protective barrier between the drug and the worker’s skin.
- Decontamination: All work surfaces, tools, and equipment used in the handling of hazardous drugs must be properly decontaminated to reduce the risk of exposure to residual drug particles.
- Hazardous Waste Disposal: Procedures for the safe disposal of hazardous drug waste are crucial to prevent environmental contamination. Designated hazardous waste containers and specialized disposal methods are used for this purpose.
By following USP 800 guidelines, pharmacies can significantly reduce the risk of exposure to hazardous drugs and create a safer environment for their employees.
Compliance and Safety Guidelines
Both USP 797 vs USP 800 establish clear compliance and safety guidelines for the handling of medications in a compounding pharmacy. Adhering to these guidelines ensures that pharmacies can operate in a safe and effective manner, meeting regulatory requirements and protecting patient health.
USP 797 Compliance Guidelines:
- Cleanroom Standards: Pharmacies must meet strict cleanroom standards and maintain proper ventilation and filtration to minimize contamination risks.
- Personnel Training: Pharmacy staff must undergo regular training to stay current with aseptic techniques and new industry standards.
- Routine Monitoring: Continuous monitoring of the environment, including air quality and equipment functionality, is necessary to maintain compliance with USP 797.
USP 800 Compliance Guidelines:
- Containment Systems: Pharmacies must use appropriate containment systems such as BSCs or CACIs when compounding hazardous drugs.
- Personal Protective Equipment (PPE): Pharmacy staff must wear the appropriate PPE, including gloves, gowns, and respiratory protection, when handling hazardous drugs.
- Cleaning Protocols: Regular cleaning and decontamination of equipment and surfaces must be conducted to reduce the risk of cross-contamination.
By adhering to these safety guidelines, compounding pharmacies can ensure that they meet the necessary standards to protect patients, staff, and the environment.
Implications for Pharmacy Practice
Both USP 797 and USP 800 Services have significant implications for pharmacy practice. Pharmacies must ensure that their facilities, staff, and procedures are compliant with both sets of guidelines to guarantee the safety of patients and pharmacy personnel.
Pharmacy Infrastructure
Pharmacies must invest in the appropriate infrastructure, such as cleanrooms for sterile compounding (USP 797) and containment systems for hazardous drug handling (USP 800). These systems are designed to ensure safety and minimize contamination risks.
Staff Training
Pharmacy staff must be regularly trained on USP 797 guidelines for sterile compounding and USP 800 guidelines for hazardous drug handling. This ensures that employees understand how to work within these environments safely and effectively.
Risk Management
Both guidelines require pharmacies to implement risk management protocols to identify potential hazards and take corrective actions before problems arise. Regular audits, monitoring, and compliance checks help ensure that these protocols are followed.
How USP 800 and USP 797 Work Together
In pharmacies that deal with both sterile compounding and hazardous drug handling, USP 797 and USP 800 must work together to ensure a safe environment. For example, in oncology pharmacies where chemotherapy drugs are compounded, both the sterility of the drug and the protection of pharmacy staff from hazardous drug exposure must be maintained. By following both sets of guidelines, pharmacies can create a comprehensive safety system that ensures both patient and worker safety.
Conclusion
USP 797 and USP 800 are both essential in ensuring safe and effective pharmacy practices. While USP 797 addresses the sterility of compounded medications, USP 800 focuses on minimizing the risks associated with hazardous drugs. Pharmacies must adhere to both sets of guidelines to maintain high standards of safety, protect patients and workers, and remain compliant with regulatory requirements.
Call to Action
If your pharmacy handles sterile compounding or hazardous drugs, ensuring compliance with USP 797 and USP 800 is crucial for maintaining safety and protecting your staff and patients. Contact us today to learn more about how we can help you ensure regulatory compliance with these important guidelines.
Frequently Asked Questions (FAQs)
- What is the difference between USP 797 and USP 800?
USP 797 focuses on sterile compounding and preventing microbial contamination, while USP 800 addresses the safe handling of hazardous drugs to protect pharmacy workers. - Why is USP 797 important for pharmacy practice?
USP 797 ensures that compounded sterile medications are safe for patients by minimizing the risk of contamination during preparation. - How can pharmacies ensure compliance with USP 800?
Pharmacies can ensure compliance by using appropriate containment systems, requiring PPE for staff, and following strict cleaning protocols for hazardous drug handling. - Can a pharmacy be compliant with both USP 797 and USP 800?
Yes, pharmacies that handle both sterile compounding and hazardous drugs must comply with both sets of guidelines to ensure safety for both patients and workers. - What are the consequences of non-compliance with USP 797 and USP 800?
Non-compliance can lead to legal penalties, increased risk of patient harm, and damage to the pharmacy’s reputation.


Leave A Comment